Intercostal muscle contraction or rib bone marrow activity? Look for ancillary clues

Clinical Nuclear Medicine

Volumn 32, Issue 9, 2007, Pages 739-740

  Basu, Sandip ^a   Alzeair, Saad ^a   Li, Geming ^a   Zhuang, Hongming ^a,b   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Intercostal muscle; Marrow stimulants; Pulmonary hypertension; Rib bone marrow

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BONE MARROW; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DRUG UPTAKE; HUMAN; INTERCOSTAL MUSCLE; MUSCLE CONTRACTION; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; RIB;

ADULT; ARTIFACTS; BONE MARROW DISEASES; HUMANS; HYPERTENSION, PULMONARY; INTERCOSTAL MUSCLES; MUSCLE CONTRACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RIBS;

EID: 34548103201     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318126c00a     Document Type: Article

References (12)

1. Aydin A, Hickeson M, Yu JQ, et al. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease. Clin Nucl Med. 2005;30:159-164.
2. Bural GG, Mavi A, Kumar R, et al. FDG uptake in intercostal muscles is an indicator of severe respiratory disease. Clin Nucl Med. 2004;29:807-808.
3. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005;45:1849-1855.
4. Kluge R, Barthel H, Pankau H, et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med. 2005;46:25-31.
5. Sugawara Y, Zasadny KR, Kison PV, et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med. 1999;40:1456-1462.
6. Plantade A, Montravers F, Selle F, et al. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy. Clin Nucl Med. 2003;28:771-772.
7. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93-98.
8. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29:161-163.
9. Aflalo-Hazan V, Gutman F, Kerrou K, et al. Increased FDG uptake by bone marrow in major beta-thalassemia. Clin Nucl Med. 2005;30:754-755.
10. Takalkar A, Yu JQ, Kumar R, et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med. 2004;29:637-639.
11. Inoue K, Okada K, Harigae H, et al. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Clin Nucl Med. 2006;31:721-723.
12. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET imaging. Clin Nucl Med. 2005;30:674.